GNH USA

Europe — EMA

Nipent (Pentostatin)

GNH USA supplies Nipent (Pentostatin), a chemotherapy antimetabolite for hairy cell leukemia and chronic lymphocytic leukemia.

Pentostatin

Request sourcing

1
Pack/s

What is Pentostatin?

Pentostatin, the active ingredient in Nipent, is an antimetabolite presented as an injectable solution for intravenous use. It is employed in the treatment of hairy cell leukemia and chronic lymphocytic leukemia in adult patients.

GNH USA supplies Nipent as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for clinical use. With a global distribution network, GNH USA ensures timely delivery and supports pharmacovigilance activities in collaboration with healthcare partners.

What is Pentostatin used for?

Pentostatin is used in hematologic malignancies that involve abnormal B‑cell proliferation.

Hairy cell leukemia: induces remission by targeting malignant B‑cells through adenosine deaminase inhibition. Chronic lymphocytic leukemia: contributes to disease control by reducing circulating lymphocyte counts.

What are the side effects of Pentostatin?

Pentostatin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Fatigue: generalized tiredness during treatment. - Low blood counts: anemia, neutropenia, or thrombocytopenia. - Fever: transient elevations in body temperature.

Serious or Rare Side Effects: - Severe infection: opportunistic infections due to profound immunosuppression. - Pulmonary toxicity: interstitial pneumonitis or fibrosis. - Renal impairment: acute kidney injury in susceptible patients.

What precautions apply to Pentostatin?

When using Pentostatin, clinicians should observe several safety measures to minimize risks.

Baseline evaluation: obtain complete blood count and renal function before initiating therapy. Infection monitoring: assess for signs of infection throughout treatment. Dose adjustments: modify dose in patients with renal insufficiency. Concomitant drugs: avoid concurrent use of other myelosuppressive agents when possible. Pregnancy and lactation: use only if potential benefit justifies potential risk; discuss with obstetric specialist. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Pentostatin interact with?

Pentostatin can interact with other medicines, affecting its efficacy or safety profile.

Major Interactions (Avoid): - Concurrent myelosuppressive chemotherapy: may cause excessive bone‑marrow suppression. - Live vaccines: increased risk of severe infection; avoid administration during treatment. - Azathioprine or cyclophosphamide: additive immunosuppression leading to heightened infection risk.

Moderate Interactions (Monitor Closely): - Allopurinol: may increase pentostatin toxicity; monitor blood counts. - Antibiotics such as trimethoprim‑sulfamethoxazole: may enhance myelosuppression; adjust dosing as needed. - Antifungal agents (e.g., fluconazole): potential pharmacokinetic interactions; observe for adverse effects.

Frequently asked questions

What is Nipent used for?+
Nipent contains the antimetabolite Pentostatin and is indicated for the treatment of certain blood cancers, specifically hairy cell leukemia and chronic lymphocytic leukemia. It works by targeting malignant lymphocytes, helping to achieve remission or disease control in adult patients under the supervision of a qualified oncologist.
How does Pentostatin work?+
Pentostatin is a purine analog that irreversibly inhibits adenosine deaminase, an enzyme essential for lymphocyte metabolism. Inhibition leads to accumulation of toxic deoxyadenosine nucleotides inside cells, causing DNA synthesis disruption and apoptosis of malignant B‑cells, which underlies its therapeutic effect in hematologic malignancies.
What is the usual dose of Pentostatin?+
The dosing regimen for Pentostatin is individualized and determined by the prescribing clinician based on the patient’s disease type, severity, renal function, and overall health status. Healthcare providers calculate the appropriate dose, schedule, and duration according to established clinical guidelines and patient-specific factors.
Is Pentostatin safe in pregnancy or breastfeeding?+
Safety data for Pentostatin during pregnancy and lactation are limited. It is generally advised to avoid use unless the potential therapeutic benefit justifies the possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and risk assessment with their obstetric and oncology specialists.
How do I order Nipent from GNH USA?+
To order Nipent, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain handling if needed), and necessary import documentation.
How does Pentostatin compare with other treatments for hairy cell leukemia?+
Pentostatin is one of the standard first‑line agents for hairy cell leukemia, offering high response rates due to its specific inhibition of adenosine deaminase. Compared with alternatives such as cladribine, Pentostatin has a similar efficacy profile but may differ in toxicity patterns, administration schedule, and patient tolerance, influencing the choice of therapy by the treating physician.
How should Nipent be stored and handled?+
Nipent must be stored at 2‑8 °C in a refrigerator. Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking. Prior to administration, follow aseptic techniques for reconstitution and ensure the product remains within the recommended temperature range throughout handling.
How is Nipent administered?+
Nipent is supplied as an injectable solution for intravenous infusion. It is administered by a qualified healthcare professional, typically as a slow infusion over a prescribed period. The exact infusion rate, frequency, and duration are determined by the treating oncologist based on the patient’s treatment protocol.
What are the most serious risks to watch for with Pentostatin?+
The most serious risks associated with Pentostatin include severe infections due to profound immunosuppression, pulmonary toxicity such as interstitial pneumonitis, and renal impairment. Patients should be monitored closely for signs of infection, respiratory distress, and changes in kidney function throughout therapy.
Who should not use Pentostatin?+
Pentostatin is contraindicated in patients with known hypersensitivity to the drug or any of its excipients. It should also be avoided in individuals with active severe infections, uncontrolled renal failure, or those receiving live vaccines during treatment. Clinicians must evaluate each patient’s medical history before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Pentostatin
Route
Intravenous Use
Manufacturer
Pfizer Italia S.R.L.
Origin
EU

Related products

Nipent 2 mg/mL

Nipent 2 mg/mL

Pentostatin · 2 mg/mL

Nipent
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Hospira, Inc.
USA
Nipent

Nipent

Pentostatin

Pfizer Holding France
EU
Nipent

Nipent

Pentostatin

Pfizer Pharma Gmbh
EU
Nipent

Nipent

Pentostatin

Pfizer Hellas A.E.
EU